Filter
1668
Text search:
drug
financing
Featured
Recommendations
113
New Publications
550
Language
Document type
No document type
1051
Studies & Reports
280
Guidelines
117
Strategic & Response Plan
105
Manuals
51
Situation Updates
35
Fact sheets
14
Training Material
7
Infographics
4
Brochures
1
Resource Platforms
1
Countries / Regions
Global
86
Kenya
72
Uganda
54
Sierra Leone
48
Nigeria
47
Western and Central Europe
45
Liberia
44
Ethiopia
44
Zambia
39
Nepal
38
Ghana
37
India
37
Malawi
37
South Africa
31
Myanmar / Burma
31
Africa
29
Tanzania
28
Rwanda
28
Bangladesh
27
Eastern Europe
27
Asia
25
Cambodia
22
Namibia
22
Latin America and the Carribbean
19
Ukraine
18
Philippines
16
Lesotho
15
South–East Asia Region
15
Botswana
13
Zimbabwe
12
Senegal
11
Indonesia
11
Mozambique
10
Congo, Democratic Republic of
8
Guinea
7
Burkina Faso
7
Haiti
7
Eswatini/ Swaziland
7
East and Southern Africa
7
Russia
7
Cameroon
6
Vietnam
6
Thailand
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Albania
5
Laos
5
Georgia
5
Pakistan
4
Germany
4
West and Central Africa
4
Western Pacific Region
4
Venezuela
4
Tajikistan
4
South Sudan
3
Afghanistan
3
Syria
3
China
3
Benin
3
Paraguay
3
Armenia
3
Jordan
2
Sudan
2
Central African Republic
2
North Macedonia
2
Sri Lanka
2
Timor Leste/ East Timor
2
Moldova
2
North America
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Somalia
1
Turkey
1
Gambia
1
Papua New Guinea
1
Peru
1
Switzerland
1
Colombia
1
Honduras
1
Bolivia
1
Libya
1
Madagascar
1
Mongolia
1
Qatar
1
Bulgaria
1
Uzbekistan
1
Kyrgyzstan
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
782
Public Health
97
Clinical Guidelines
68
Women & Child Health
43
Key Resources
43
Capacity Building
11
Pharmacy & Technologies
10
Toolboxes
TB
213
HIV
209
Mental Health
83
AMR
68
COVID-19
48
Health Financing Toolbox
48
Pharmacy
42
NTDs
33
Global Health Education
30
Malaria
30
NCDs
27
Planetary Health
26
Caregiver
20
Ebola & Marburg
18
Disability
13
Conflict
12
Rapid Response
11
Polio
10
Refugee
10
2.0 Rapid Response
5
Natural Hazards
4
Zika
2
Social Ethics
2
Cholera
1
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in t
...
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assi
...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect
...
The COVID-19 pandemic demonstrated that
the world was not well prepared to respond
to an infectious disease threat of this magnitude. Countries across all socioeconomic and development categories have struggled
to implement effective national responses. Substantial amounts of additional investmen
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health
...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed wh
...
World Drug Report 2017
-5-
Accessed: 14.03.2019
Strategic Overview
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass
...
Health Care Financing in Nepal
recommended
Developed through broad and inclusive consultation, and aligned with the WHO Global Health Sector Strategies and the Sustainable Development Goals, the framework promotes a people-centred approach and antimicrobial stewardship across 5 key domains: prevention and response, surveillance, research and
...
